Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine

  • Authors:
    • Wenfang Xu
    • Yong Wu
    • Jiaoping Zhao
    • Jiangnan Chen
    • Weiyang Zhang
  • View Affiliations / Copyright

    Affiliations: Clinical Laboratory, Shaoxing Municipal Hospital, Shaoxing, Zhejiang 312000, P.R. China, Medical Department, Shaoxing Municipal Hospital, Shaoxing, Zhejiang 312000, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3090-3096
    |
    Published online on: February 18, 2020
       https://doi.org/10.3892/etm.2020.8532
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In the present study, the effect of thieno[3,4‑d]pyrimidine (TEP) on the transcription of human immunodeficiency virus type 1 (HIV‑1) was investigated. To the best of the authors' knowledge, this is the first study describing the effect of TEP on the transcription of HIV‑1. The present results identified a marked decrease in the production of the HIV‑1 genome in 293T cells after treatment with TEP. The treatment of HIV‑1infected 293T cells with TEP led to the upregulation of retinoblastoma binding protein 4 (RbAp48) mRNA and protein. The activity of long terminal repeats (LTRs) was decreased by 19, 24, 29, 34, 38, 41, 52, 63, 76 and 92% in treatments with concentrations of 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, 2.25 and 2.5 µM TEP, respectively. The p65 translocation to the nucleus was markedly reduced in 293T cells treated with TEP for 48 h. A marked decrease was observed in the production of HIV‑1 in 293T cells with the increase in concentration of pRbAp48. In 293T cells, RbAp48 and TEP decreased tumor necrosis factor‑α and phorbol 12‑myristate 13‑acetate‑induced activity of LTR. Therefore, the present study suggested that TEP inhibited transcription of HIV‑1 through upregulation of RbAp48 expression and activation of the NF‑κB pathway. Therefore, TEP may be used for the treatment of HIV‑1 infection.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Mohammadi P, di Iulio J, Muñoz M, Martinez R, Bartha I, Cavassini M, Thorball C, Fellay J, Beerenwinkel N, Ciuffi A, et al: Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. PLoS Pathog. 10(e1004156)2014.PubMed/NCBI View Article : Google Scholar

2 

Mbonye U and Karn J: Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure. Virology. 454-455:328–339. 2014.PubMed/NCBI View Article : Google Scholar

3 

Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, et al: HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 345:179–183. 2014.PubMed/NCBI View Article : Google Scholar

4 

Van Lint C, Bouchat S and Marcello A: HIV-1 transcription and latency: An update. Retrovirology. 10(67)2013.PubMed/NCBI View Article : Google Scholar

5 

Loyola A and Almouzni G: Histone chaperones, a supporting role in the limelight. Biochim Biophys Acta. 1677:3–11. 2004.PubMed/NCBI View Article : Google Scholar

6 

Allen HF, Wade PA and Kutateladze TG: The NuRD architecture. Cell Mol Life Sci. 70:3513–3524. 2013.PubMed/NCBI View Article : Google Scholar

7 

Zhang W, Tyl M, Ward R, Sobott F, Maman J, Murthy AS, Watson AA, Fedorov O, Bowman A, Owen-Hughes T, et al: Structural plasticity of histones H3-H4 facilitates their allosteric exchange between RbAp48 and ASF1. Nat Struct Mol Biol. 20:29–35. 2013.PubMed/NCBI View Article : Google Scholar

8 

O'Connor MD, Wederell E, Robertson G, Delaney A, Morozova O, Poon SSS, Yap D, Fee J, Zhao Y, McDonald H, et al: Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance. Exp Hematol. 39:866–79.e1. 2011.PubMed/NCBI View Article : Google Scholar

9 

Creekmore AL, Walt KA, Schultz-Norton JR, Ziegler YS, McLeod IX, Yates JR and Nardulli AM: The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor α mediated gene expression. Mol Cell Endocrinol. 291:79–86. 2008.PubMed/NCBI View Article : Google Scholar

10 

Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S and Hayashi Y: Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy. J Exp Med. 205:2915–2927. 2008.PubMed/NCBI View Article : Google Scholar

11 

Yang J, Yang Z, Lv H, Lou Y, Wang J and Wu N: Bridging HIV-1 cellular latency and clinical long-term non-progressor: An interactomic view. PLoS One. 8(e55791)2013.PubMed/NCBI View Article : Google Scholar

12 

O'Doherty U, Swiggard WJ and Malim MH: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol. 74:10074–10080. 2000.PubMed/NCBI View Article : Google Scholar

13 

Casabianca A, Gori C, Orlandi C, Forbici F, Federico Perno C and Magnani M: Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. Mol Cell Probes. 21:368–378. 2007.PubMed/NCBI View Article : Google Scholar

14 

Jablonski JA and Caputi M: Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J Virol. 83:981–992. 2009.PubMed/NCBI View Article : Google Scholar

15 

Yedavalli VSRK and Jeang KT: Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci USA. 107:14787–14792. 2010.PubMed/NCBI View Article : Google Scholar

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

17 

Wang XM, Nadeau PE, Lin S, Abbott JR and Mergia A: Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB. J Virol. 85:5483–5493. 2011.PubMed/NCBI View Article : Google Scholar

18 

Vemula SV, Veerasamy R, Ragupathy V, Biswas S, Devadas K and Hewlett I: HIV-1 induced nuclear factor IB (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region. Viruses. 7:543–558. 2015.PubMed/NCBI View Article : Google Scholar

19 

Kumar A, Darcis G, Van Lint C and Herbein G: Epigenetic control of HIV-1 post integration latency: Implications for therapy. Clin Epigenetics. 7(103)2015.PubMed/NCBI View Article : Google Scholar

20 

Coull JJ, Romerio F, Sun JM, Volker JL, Galvin KM, Davie JR, Shi Y, Hansen U and Margolis DM: The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol. 74:6790–6799. 2000.PubMed/NCBI View Article : Google Scholar

21 

Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D and Chattopadhyay S: Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology. 400:76–85. 2010.PubMed/NCBI View Article : Google Scholar

22 

Nishitsuji H, Abe M, Sawada R and Takaku H: ZBRK1 represses HIV-1 LTR-mediated transcription. FEBS Lett. 586:3562–3568. 2012.PubMed/NCBI View Article : Google Scholar

23 

Rom S, Reichenbach NL, Dykstra H and Persidsky Y: The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity. Front Microbiol. 6(878)2015.PubMed/NCBI View Article : Google Scholar

24 

Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E and Greene WC: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139–149. 2006.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu W, Wu Y, Zhao J, Chen J and Zhang W: Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine. Exp Ther Med 19: 3090-3096, 2020.
APA
Xu, W., Wu, Y., Zhao, J., Chen, J., & Zhang, W. (2020). Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine. Experimental and Therapeutic Medicine, 19, 3090-3096. https://doi.org/10.3892/etm.2020.8532
MLA
Xu, W., Wu, Y., Zhao, J., Chen, J., Zhang, W."Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine". Experimental and Therapeutic Medicine 19.4 (2020): 3090-3096.
Chicago
Xu, W., Wu, Y., Zhao, J., Chen, J., Zhang, W."Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine". Experimental and Therapeutic Medicine 19, no. 4 (2020): 3090-3096. https://doi.org/10.3892/etm.2020.8532
Copy and paste a formatted citation
x
Spandidos Publications style
Xu W, Wu Y, Zhao J, Chen J and Zhang W: Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine. Exp Ther Med 19: 3090-3096, 2020.
APA
Xu, W., Wu, Y., Zhao, J., Chen, J., & Zhang, W. (2020). Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine. Experimental and Therapeutic Medicine, 19, 3090-3096. https://doi.org/10.3892/etm.2020.8532
MLA
Xu, W., Wu, Y., Zhao, J., Chen, J., Zhang, W."Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine". Experimental and Therapeutic Medicine 19.4 (2020): 3090-3096.
Chicago
Xu, W., Wu, Y., Zhao, J., Chen, J., Zhang, W."Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4‑d]pyrimidine". Experimental and Therapeutic Medicine 19, no. 4 (2020): 3090-3096. https://doi.org/10.3892/etm.2020.8532
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team